Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
PaperCitations, authors & open-access status
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 398 citations, 2019 year and closed oa status.
398
Citations
2019
Year
closed
OA Status